Roth Capital Starts Inotek Pharmaceuticals (ITEK) at Buy

December 1, 2016 9:07 AM EST
Get Alerts ITEK Hot Sheet
Price: $1.78 --0%

Rating Summary:
    4 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade ITEK Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Roth Capital initiated coverage on Inotek Pharmaceuticals (NASDAQ: ITEK) with a Buy rating and a price target of $10.

For an analyst ratings summary and ratings history on Inotek Pharmaceuticals click here. For more ratings news on Inotek Pharmaceuticals click here.

Shares of Inotek Pharmaceuticals closed at $6.40 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment